Higher levels of this ADAMTS subtype have also been associated with pancreatic and hepatocellular cancer [43] whereas ADAMTS-1 mRNA levels are unchanged in the onset and progression of kidney cancer [46] and decreased in lung carcinomas [41]. Here, ADAMTS1 is linked to hepatocellular carcinoma.